PNC Financial Services Group’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.58K | Buy |
4,428
+615
| +16% | +$775 | ﹤0.01% | 4089 |
|
2025
Q1 | $3.48K | Buy |
3,813
+3,476
| +1,031% | +$3.17K | ﹤0.01% | 4178 |
|
2024
Q4 | $536 | Buy |
337
+137
| +69% | +$218 | ﹤0.01% | 4516 |
|
2024
Q3 | $392 | Hold |
200
| – | – | ﹤0.01% | 4595 |
|
2024
Q2 | $328 | Sell |
200
-110
| -35% | -$180 | ﹤0.01% | 4587 |
|
2024
Q1 | $1.59K | Hold |
310
| – | – | ﹤0.01% | 4260 |
|
2023
Q4 | $1.78K | Buy |
310
+110
| +55% | +$630 | ﹤0.01% | 4218 |
|
2023
Q3 | $956 | Sell |
200
-100
| -33% | -$478 | ﹤0.01% | 4383 |
|
2023
Q2 | $1.28K | Buy |
300
+200
| +200% | +$850 | ﹤0.01% | 4467 |
|
2023
Q1 | $531 | Hold |
100
| – | – | ﹤0.01% | 4520 |
|
2022
Q4 | $628 | Hold |
100
| – | – | ﹤0.01% | 4482 |
|
2022
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 4294 |
|
2022
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 4319 |
|
2022
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 4324 |
|
2021
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 4135 |
|
2021
Q3 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 4089 |
|